PMA P240009S006

Device
Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
Applicant
Contego Medical, Inc.
PMA number
P240009
Supplement
S006
Product code
NIM
Decision date
2026-11-04
Classification
Cardiovascular
Generic name
Stent, carotid
Approval order statement
The Neuroguard IEP Direct 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection used in conjunction with the Neuroguard IEP Embolic Protection System is indicated for improving carotid luminal diameter in subjects at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below: • Patients with = 50% symptomatic stenosis of the internal carotid artery (ICA) or common carotid artery (CCA) as determined by angiography, CTA, or duplex ultrasound or patients with = 70% asymptomatic stenosis of the internal carotid artery (ICA) or common carotid artery (CCA) as determined by angiography, CTA, or duplex ultrasound • Patients with a reference vessel diameter of 4.0 - 8.0 mm • At least 5 cm of atherosclerosis free space in the ipsilateral common carotid artery between the sheath insertion site and the proximal edge of the target lesion. This device is also indicated for post-dilation of the stent component with simultaneous capture and removal of embolic material.

Current openFDA PMA Record#

Device
Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
Applicant
Contego Medical, Inc.
PMA number
P240009
Supplement
S006
Product code
NIM
Generic name
Stent, carotid
Decision date
2026-11-04
Decision code
APPR
Date received
2025-09-29
Supplement type
Panel Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
The Neuroguard IEP Direct 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection used in conjunction with the Neuroguard IEP Embolic Protection System is indicated for improving carotid luminal diameter in subjects at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below: • Patients with = 50% symptomatic stenosis of the internal carotid artery (ICA) or common carotid artery (CCA) as determined by angiography, CTA, or duplex ultrasound or patients with = 70% asymptomatic stenosis of the internal carotid artery (ICA) or common carotid artery (CCA) as determined by angiography, CTA, or duplex ultrasound • Patients with a reference vessel diameter of 4.0 - 8.0 mm • At least 5 cm of atherosclerosis free space in the ipsilateral common carotid artery between the sheath insertion site and the proximal edge of the target lesion. This device is also indicated for post-dilation of the stent component with simultaneous capture and removal of embolic material.